PrEPVacc
PrEP Vacc Registration Cohort Get Involved Contact Member's Area
Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive
Partners Organisation and Governance Our Funders FAQs
PrEPVaccRegistration CohortGet Involved News Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive About Partners Organisation and Governance Our Funders FAQs ContactMember's Area
PrEPVacc
An African-led, European-supported HIV prevention project running in four countries in East and Southern Africa from 2018 to 2024

News Archive

 
Featured
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
3 December 2024
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
3 December 2024
3 December 2024
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
29 October 2024
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
29 October 2024
29 October 2024
PrEPVacc meets the media in Masaka
4 September 2024
PrEPVacc meets the media in Masaka
4 September 2024
4 September 2024
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
11 August 2024
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
11 August 2024
11 August 2024
FAQs for PrEPVacc's vaccine result
5 August 2024
FAQs for PrEPVacc's vaccine result
5 August 2024
5 August 2024
Media coverage of PrEPVacc's July 2024 vaccine result announcement
23 July 2024
Media
Media coverage of PrEPVacc's July 2024 vaccine result announcement
23 July 2024
Media
23 July 2024
Media
Eddagala ly’okugema eryagezeseddwa mu kunoonyereza kwa PrEPVacc teryasobodde kuziyiza kawuka ka Siriimu
23 July 2024
Eddagala ly’okugema eryagezeseddwa mu kunoonyereza kwa PrEPVacc teryasobodde kuziyiza kawuka ka Siriimu
23 July 2024
23 July 2024
Taarifa kwa Umma: Chanjo za VVU zilizojaribiwa katika utafiti wa PrEPVacc zashindwa kupunguza maambukizi
23 July 2024
Taarifa kwa Umma: Chanjo za VVU zilizojaribiwa katika utafiti wa PrEPVacc zashindwa kupunguza maambukizi
23 July 2024
23 July 2024
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
23 July 2024
Research
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
23 July 2024
Research
23 July 2024
Research
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda
23 July 2024
Research
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda
23 July 2024
Research
23 July 2024
Research
03-Yellow_EDCTP.png
flag_yellow_low.jpg
 

This project is part of the EDCTP2 Programme supported by the European Union

 
prepvacc@gmail.com
Hours
Featured
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc meets the media in Masaka
PrEPVacc meets the media in Masaka
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
Joining the studyFAQs Partners of PrEPVacc
PrEPVacc-logo-reverse-rgb.png
 

Contact: prepvacc@gmail.com | Accessibility

© PrEPVacc Investigators 2026 | All rights reserved